Wordt geladen...
Cetuximab and biomarkers in non-small-cell lung carcinoma
Cancer progression is a highly complex process that is driven by a constellation of deregulated signaling pathways and key molecular events. In non-small-cell lung cancer (NSCLC), as in several other cancer types, the epidermal growth factor receptor (EGFR) and its downstream signaling components re...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3421478/ https://ncbi.nlm.nih.gov/pubmed/22904614 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S24217 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|